| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_87f39604c4cc3ec0815608a54e65bf27 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12R2001-25
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12R2001-125 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-66
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N1-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N1-02 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-66
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L33-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10 |
| filingDate |
2014-05-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a35d506e55800c6dfbf55b49d9215655
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7ad04dbcbc66caed8e0473c832d87d16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c504e301278335f9e406e523ac768d3e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_15c12960a3231a1a6f33ab9f0762f007
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_24b9d58181fc57977f20b4772515b04c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_11f726d9e2f6d5c8f1b427363bfe6cf4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e5d2576a999098abdd9051c292215e4b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2afaf3035f73e53ab28251a191515178 |
| publicationDate |
2015-12-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20150135649-A |
| titleOfInvention |
Lactobacillus brevis JB PML-131 strain having antidiabetic and anti-hyperlipidemia activity and uses thereof |
| abstract |
The present invention relates to the use of Lactobacillus brevis ( Lactobacillus brevis) brevis) JB PML-131 strain (Accession No KACC91950P), the above strain or the anti-diabetic and anti-hyperlipemia microbial agent comprising the anti-diabetic or anti-hyperlipidemic culturing compositions and the strain for containing a culture broth thereof as an active ingredient And a method for manufacturing the same. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/TW-I604051-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113151103-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113151103-B |
| priorityDate |
2014-05-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |